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The majority of AMPA receptors in the adult brain contain GluA2 subunits, which can be
edited at the Q/R site, changing a glutamine to an arginine within the ion pore. Q/R editing
renders AMPARs virtually Ca2+-impermeable, which is important for normal AMPA
receptor function. Thus, all GluA2 subunits are Q/R-edited in the adult brain. However,
it has remained controversial precisely when editing sets in during development. In the
present study, we show that GluA2 mRNA is very rapidly Q/R-edited immediately after
its appearance, which is after 4.5 days of differentiation from 46C embryonic stem cells
(ESCs) to neuroepithelial precursor cells (NEPs). At this time point, most of the GluA2
transcripts were already edited, with only a small fraction remaining unedited, and half
a day later all GluA2 transcripts were edited. This can be explained by the observation
that the enzyme that Q/R-edits GluA2 transcripts, ADAR2, is already expressed in the
cell well before GluA2 transcription starts, and later is not significantly upregulated any
more. Editing at another site works differently: The R/G site within the ligand-binding
domain was never completely edited at any of the developmental stages tested, and the
enzyme that performs this editing, ADAR1, was significantly upregulated during neural
differentiation. This confirms previous data suggesting that R/G editing, in contrast to
Q/R editing, progresses gradually during development.
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1. Introduction
The molecular diversity of ionotropic glutamate receptors (iGluRs) is large, since 18 different
subunits have been discovered inmammals. These subunits are grouped into four different subfam-
ilies, namely α-amino-3-hydroxy-5-methyl-4-isoaxole propionic acid receptors (AMPARs), kainate
receptors (KARs), delta receptors, and N-methyl-D-aspartate receptors (NMDARs) (Mayer and
Westbrook, 1987; Collingridge and Lester, 1989; Hollmann and Heinemann, 1994). Their molec-
ular diversity is further increased by a number of post-transcriptional (RNA editing and splicing)
and post-translational (e.g., N-glycosylation, phosphorylation, and palmitoylation) modifications.
Both splicing and editing of AMPAR subunits impact their physiological properties.
All AMPAR subunits are spliced at the flip/flop splicing site, which leads to the expression
of one of two 115 bp-long mutually exclusive sequences (Sommer et al., 1990). Flip splice vari-
ants activate faster and desensitize four times slower than flop splice variants (Sommer et al.,
1990; Mosbacher et al., 1994; Koike et al., 2000), while flop variants show reduced current
responses to glutamate than the flip variants (Sommer et al., 1990). Regarding the temporal
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expression of flip and flop splice variants, the flip variants pre-
dominate during early development, since the expression of flop
splice variants is very low prior to P8 (Monyer et al., 1991).
Besides flip/flop splicing, the AMPAR subunits GluA2
through GluA4 undergo RNA editing at the R/G site; however,
GluA2 is the only AMPAR which is edited at the Q/R editing
site. During A-to-I editing, a genetically encoded adenosine in
the pre-mRNA is converted into an inosine by oxidative deami-
nation, and the inosine is then in turn read as a guanosine during
translation (Benne et al., 1986). The AMPAR subunits GluA2 to
GluA4 can undergo editing at the R/G site in the S2 domain
of the receptor (Lomeli et al., 1994). R/G editing exchanges the
genetically encoded arginine (R; encoded by AGA) at position
764 to a glycine (G; here encoded by the non-canonical triplet
IGA, which is translated as GGA) (Lomeli et al., 1994). R/G-
edited AMPARs desensitize faster and also recover faster from
desensitization than unedited subunits (Lomeli et al., 1994). R/G
editing gradually increases during neural development and upon
neuronal cell maturation (Lomeli et al., 1994; Geiger et al., 1995;
Orlandi et al., 2011). In adult rodent and human brains, roughly
50–85% of AMPARs are edited at the R/G site (Lomeli et al.,
1994; Lai et al., 1997; Vollmar et al., 2004). More precisely, in the
human hippocampus and neocortex, 55% and 60%, respectively,
of AMPARs are R/G-edited (Vollmar et al., 2004).
In GluA2, Q/R editing leads to the exchange of the glu-
tamine (Q; encoded by CAG) at the tip of the pore loop (posi-
tion 607) to arginine (R; here encoded by the non-canonical
triplet CIG, which is translated as CGG) (Sommer et al., 1991;
Kuner et al., 2001). Since arginine is positively charged in con-
trast to the uncharged glutamine, one key feature of the ion
pore is dramatically altered: Q/R-unedited GluA2 subunits are
Ca2+-permeable, whereas Q/R-edited GluA2 subunits are virtu-
ally Ca2+-impermeable (Hollmann et al., 1991; Burnashev et al.,
1992). Besides determining the Ca2+ permeability of AMPARs,
Q/R editing of GluA2 also affects other electrophysiological
properties. AMPARs with edited GluA2 show a linear current-
voltage relationship, whereas AMPARs with unedited GluA2
have an inwardly rectifying current-voltage relationship (Bowie
and Mayer, 1995; Geiger et al., 1995; Kamboj et al., 1995; Koh
et al., 1995; Swanson et al., 1997). Furthermore, the single chan-
nel conductance of edited GluA2 is lower than that of unedited
GluA2 (Swanson et al., 1997).
The majority of AMPARs in vivo are GluA1/GluA2 or
GluA2/GluA3 heterotetramers (Geiger et al., 1995; Wenthold
et al., 1996; Tsuzuki et al., 2001; Sans et al., 2003), and GluA2
dominates the receptor complex to the effect that the Ca2+ per-
meability and other electrophysiological properties of AMPARs
depend on the Q/R editing state of the incorporated GluA2 sub-
unit (Burnashev et al., 1992). In the adult rodent and human
brain, virtually all GluA2 subunits are edited at the Q/R site
(Paschen and Djuricic, 1995; Carlson et al., 2000; Kawahara et al.,
2003; Jacobs et al., 2009; Barbon et al., 2010), thus, the majority
of AMPARs is virtually Ca2+-impermeable. The extent to which
GluA2 is edited at the Q/R site during embryonic and postna-
tal development is still a matter of debate and results obtained
by several research groups differ. GluA2 was found to be almost
fully edited at E15 in mice (Jacobs et al., 2009; Wahlstedt et al.,
2009) and at P7 (the earliest time point examined in that par-
ticular study) in rats (Longone et al., 1998), but small amounts
of unedited GluA2 subunits were found between E14 and P1 in
rat neocortical organotypic slices as well (Hamad et al., 2011).
One study found approximately 60% of GluA2 to be unedited at
the Q/R site in human neural progenitor cells (Whitney et al.,
2008). In human fetal brains, however, GluA2 was shown to be
already fully edited at the Q/R site (Kawahara et al., 2004; Shtrich-
man et al., 2012). Furthermore, GluA2 was found to be com-
pletely edited prior to neuronal differentiation in human NT2
cells (Barbon et al., 2003). By contrast, in another study in human
NT2 cells, GluA2 was completely edited at the Q/R site only
after 3 weeks of retinoic acid (RA) treatment to induce neuronal
differentiation (Lai et al., 1997). Interestingly, it was suggested
that Q/R-unedited GluA2 does not play any important role dur-
ing neural development at all, since GluA2R/R mice, which are
genetically edited at the Q/R site, show no differences in brain
architecture (Kask et al., 1998).
RNA editing is mediated by the family of adenosine deam-
inases that act on RNA (ADARs). To date, three members of
this family have been identified in rodents, namely ADAR1
(O’Connell et al., 1995), ADAR2 (Melcher et al., 1996b), and
ADAR3 (Melcher et al., 1996a). Most of the editing targets for
ADAR1 and ADAR2 encode for ion channels involved in neu-
rotransmission, e.g., potassium channels (KV1.1; Bhalla et al.,
2004), serotonin receptors (5-HT-2CR; Burns et al., 1997), γ -
aminobutyric acid (GABA) receptors (GABAA; Rula et al., 2008),
and iGluRs (GluA2 to GluA4; GluK1 and GluK2; Sommer et al.,
1991; Lomeli et al., 1994). In the case of AMPARs, ADAR1 almost
exclusively edits the R/G editing site, whereas ADAR2 edits both
the R/G and Q/R editing sites (Wong et al., 2001).
Since the exact onset of Q/R editing of GluA2 during neu-
ral development has remained unclear thus far, and since one
study found approximately 60% Q/R-unedited GluA2 in human
neural progenitor cells (Whitney et al., 2008), we investigated
the expression of GluA2 and its editing enzyme ADAR2 as well
as the editing state of AMPARs during neural development in
detail. For this, we used the genetically engineered 46C embry-
onic stem cell (ESC) line (Figure 1), which was generated by
subcloning the CDS of EGFP as well as a puromycin resistance
gene under control of the Sox1 promoter into E14Tg2a.IV cells
(Aubert et al., 2003; Ying et al., 2003). Since Sox1 is the earliest
known neuroectodermal marker (Wood and Episkopou, 1999),
the cells show green fluorescence as soon as they are differen-
tiated into Sox1-positive neuroepithelial precursor cells (NEPs).
Subsequently, NEPs can be differentiated either into neurons via
the treatment with retinoic acid (RA), or into radial glia-like neu-
ral stem cells (NSCs) via the prolonged cultivation in the neu-
roinductive medium N2B27 and the addition of basic fibroblast
growth factor (bFGF) and epidermal growth factor (EGF) (Conti
et al., 2005; Pollard et al., 2006; Muth-Köhne et al., 2010a). 46C
NSCs can then be differentiated into astrocytes via the addi-
tion of fetal calf serum (FCS) (Glaser et al., 2007; Muth-Köhne
et al., 2010a). We and others have shown that 46C ESCs and
46C-derived cells express appropriate stem cell and differentia-
tion markers (Ying et al., 2003; Conti et al., 2005; Pollard et al.,
2006; Glaser et al., 2007; Muth-Köhne et al., 2010a; Pachernegg
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FIGURE 1 | 46C ESCs (Aubert et al., 2003; Ying et al., 2003) were
differentiated into NEPs via the prolonged cultivation in N2B27.
Subsequently, NEPs were selected by treatment with puromycin. NEPs were
then differentiated either into early neurons by addition of retinoic acid, or into
NSCs by addition of bFGF and EGF. Astrocytes were generated from NSCs by
treatment with FCS.
et al., 2013). In this study, we show that ADAR2 is expressed both
at themRNA and protein levels prior to GluA2.Moreover, GluA2
mRNA is fully edited at the Q/R site before its protein expression
sets in in early neurons.
2. Materials and Methods
2.1. Cell Culture
All 46C cell cultures were maintained at 37◦C and 5% CO2. 46C
ESCs were cultured in GMEM containing 10% FCS, 10% tryp-
tose phosphate, 0.1mM 2-mercaptoethanol, 1.8mM glutamine,
and 1000U/ml leukemia inhibitory factor (LIF; Millipore). NEPs
were differentiated from 46C ESCs by incubation in a neuroin-
ductive medium (N2B27) as described previously (Ying et al.,
2003). NSCs were differentiated fromNEPs by prolonged cultiva-
tion in N2B27 medium and the addition of EGF and bFGF (both
10 ng/ml; Preprotech) (Conti et al., 2005). NEPs were differenti-
ated into neurons via treatment with RA (10µM) for 10 days, and
NSCs were differentiated into astrocytes by adding 5% FCS to the
medium for 14 days. Cells were allowed to grow for 2 days before
RNA or protein isolation.
2.2. Reverse Transcription and Quantitative Real
Time PCR
Total RNA was isolated from cell cultures and control tissue
(mouse whole brain from postnatal day 3; P3) using the GenE-
lute Mammalian Total RNAMini-Kit (Sigma-Aldrich) according
to the manufacturer’s protocol. The total RNA isolation proce-
dure included a DNase I (Promega) treatment. Per sample, 2µg
of RNAwas used in reverse transcription reactions (SuperScriptII
TABLE 1 | Primers used in PCRs and qRT-PCRs.
Gen Sequence 5′ → 3′
GluA1 accatgaatgagtacattgagc
tcgctacgggatttgtagc
GluA2 (R/G) atgaatgagtacatcgagcag
caaagccaccagcattgc
GluA 2 (Q/R) cctggtcagcagatttagcc
cgacaccatcctctctacag
ccctttggatttcctgactc (antisense-2)
GluA3 accatgaatgagtacattgagc
tgcccgtgatttgtaacag
GluA4 atgaatgaatacattgagcagc
caaagccaccagcattgc
ADAR1 agactctcaccagctgac
atgtctcgcaggcttttctt
ADAR2-long agactctcaccagctgac
agaagtagatgggttccacg
ADAR2-short gtgctagaggaaccagcag
agaagtagatgggttccacg
β-actin cgttgacatccgtaaagacct
caaagccatgccaatgttgtctct
GAPDH catcaacgaccccttcatt
ctccacgacatactcagcac
ubiquitin ctgggcggttgcttt
ggttgactccttctggatgtt
All primer pairs span at least one exon-exon junction and were designed by using Primer3
(http://primer3.ut.ee/) with similar primer efficiencies (ranging between 89 and 96%),
annealing temperatures, product lengths, and GC contents.
Reverse Transcriptase; Invitrogen) to generate cDNA. The cDNA
was primed from random hexamer primers (Roche Diagnos-
tics). In addition, a negative control was included, in which the
amount of total RNA added to the other reactions was substi-
tuted by ddH20. Prior to the quantitative real time PCRs (qRT-
PCRs), every cDNA sample (and the negative control) was sub-
jected to a PCR (Taq Polymerase; Invitrogen) and subsequent
agarose gel analysis to control for possible genomic DNA con-
tamination. Subsequently, 50 ng of cDNA per sample were used
as template in qRT-PCRs on the Roche Light Cycler 2.0 using
the FastStart DNA MasterPLUS SYBR Green I Kit (both Roche
Diagnostics) according to the manufacturer’s instructions. The
reaction was performed with an initial pre-incubation for 10 min
at 95◦C, followed by 40 amplification cycles (95◦C for 10 s, 59◦C
for 10 s, and 72◦C for 20 s). A melting cycle was performed to
determine the melting temperatures of the amplified products
and to confirm their specificity (ramping at maximal speed to
95◦C, immediately cooling down to 65◦C for 15 s, and melt-
ing by increasing the temperature to 95◦C at a rate of 0.1◦C/s).
Whole brain RNA of neonatal (P3) C57BL/6 mice served as pos-
itive control; brains were removed from mice in accordance with
the Ruhr University animal treatment guidelines. For primer
sequences, see Table 1. qRT-PCR results were analyzed using
Roche LightCycler Software 3.5 (Roche Diagnostics). Quantita-
tive real time data was obtained by mathematical modeling as
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described previously (Pfaﬄ, 2001; Muth-Köhne et al., 2010a,b;
Pachernegg et al., 2013). The expression levels of the genes of
interest were normalized to the expression levels of the house-
keeping genes β-actin, GAPDH, and ubiquitin (21Ct method).
To additionally compare the expression of genes in different 46C
cell types to their expression in a control, the data was also nor-
malized to the expression of genes in mouse whole brain (211Ct
method). Statistics were calculated using Prism 5.0 software
(GraphPad).
2.3. Editing Assays
To analyze the editing state of AMPARs, five different editing
assay approaches were tested (Figure 2). Since this study focused
primarily on the Q/R editing of GluA2, the assays were mainly
tested with this subunit. For all approaches, 50–100 ng cDNA
were used as a template in PCRs (Phusion Polymerase, Promega)
to amplify the AMPAR fragment which contains the editing site
in question. For all editing assays except for those involving sticky
end and SLIC cloning (see below), semi-nested PCRs were per-
formed to increase the specificity of the PCR fragments. The
GluA2 primers for semi-nested PCRs were based on the study by
Whitney et al. (2008). For primer sequences, see Table 1. The 5
different editing assay approaches are described in the following.
2.3.1. Restriction Digest with BbvI
Figure 2A This approach is based on the observation that edited
and unedited GluA2 yield different restriction fragment patterns
upon restriction digest with BbvI (Whitney et al., 2008). In Q/R-
edited GluA2, one of the BbvI restriction sites is lost, yielding two
DNA fragments (225 bp and 46 bp, respectively) after a restric-
tion with BbvI. By contrast, in Q/R-unedited GluA2 cDNA, three
DNA fragments (145 bp, 80 bp, and 46 bp) are obtained after
a restriction digest with BbvI. Following the restriction digest,
the DNA fragments were separated by agarose (2% w/v) gel
electrophoresis.
In the other editing assays, the PCR products were subcloned
into the pSGEM vector, which was then transformed into E.
coli bacteria (heat shock transformation), individual clones were
picked, and the plasmid DNA was then isolated from bacte-
ria and sequenced (capillary sequencer Genetic Analyzer 3130xl;
Applied Biosystems). The DNA sequencing-based editing assay
approaches differed in the way the PCR products were subcloned
into the pSGEM plasmid.
2.3.2. Blunt end cloning
Figure 2B The pSGEM vector was cut with EcoRV (New England
Biolabs) to generate blunt ends and was subsequently dephos-
phorylated by treatment with Antarctic Phosphatase (New Eng-
land Biolabs). The PCR fragments were then phosphorylated by
treatment with polynucleotide kinase (Promega). For the ligation
reaction, plasmid and DNA inserts were incubated with 2.5U T4
ligase (Fermentas) at 16◦C over night.
2.3.3. Ligation with Subsequent Restriction
Figure 2C After generating blunt-ended PCR fragments and
EcoRV-cut (New England Biolabs) plasmid DNA, the dephos-
phorylation of the vector DNA as well as the phosphorylation of
the PCR fragments was skipped. Plasmid DNA and PCR frag-
ments were directly ligated and the ligation product was then
cut with EcoRV (New England Biolabs) to linearize re-ligated
plasmid DNA that did not incorporate a PCR fragment.
2.3.4. Sticky end Cloning
Figure 2DTail primers were used to insert restriction sites (EcoRI
and BamHI) at the 5′ and 3′ end of the PCR products, respec-
tively. Both the DNA fragments and the plasmid DNA were then
digested with EcoRI and BamHI (New England Biolabs) and
ligated.
2.3.5. SLIC
Figure 2E For Sequence and Ligation Independent Cloning
(SLIC; Li and Elledge, 2008), SLIC primers were used which add
16 bp to the PCR products; this overhang is homologous to the
vector sequence adjacent to the EcoRV restriction site. The plas-
mid DNA was then linearized with EcoRV (New England Bio-
labs), and both plasmid and PCR fragments were treated with
T4 DNA polymerase (Promega) to generate 5′ overhangs. Sub-
sequently, vector and insert DNAs were annealed for 30min at
37◦C and the recombination intermediate was then transformed
into E. coli bacteria (heat shock transformation).
2.4. Western Blotting
Total membrane proteins of cell cultures were prepared by
hypotonic lysis (10mM HEPES/KOH, 1.5mM KCl, 10mM
MgCl2, 0.5mM DTT) followed by ultracentrifugation to pel-
let membrane-bound proteins (100,000 g; 1 h). For SDS-PAGE,
50µg of membrane proteins were loaded per sample. After
transferring the proteins to nitrocellulose membranes, the mem-
branes were reversibly stained with Ponceau S (0.2% Ponceau S,
3% trichloroacetic acid, 3% sulfosalicylic acid) to check for the
proper transfer of proteins onto the membrane. For immunoblot
analysis, the following primary antibodies were used: anti-
calnexin anti-ADAR2 (1:500; Santa Cruz Biotechnology) and
anti-GluA2 (1:500; BD Biosciences). For detection, appropri-
ate HRP-conjugated secondary antibodies (1:10,000; Sigma) were
used.Whole brain proteins of neonatal (P3) C57BL/6mice served
as positive control. For the removal of antibodies from previ-
ously probedWestern blots to allow reprobing of the membranes
with another antibody, the membranes were incubated for 2 h in
stripping buffer (25mM glycine; pH 2.0, 1% SDS).
3. Results
3.1. Expression of GluA2 and ADARs in 46C Cells
In this study, the mRNA expression of GluA2 in 46C ESCs, NEPs,
NSCs, neurons, and astrocytes (Muth-Köhne et al., 2010a,b;
Pachernegg et al., 2013) was verified via qRT-PCRs.Moreover, the
mRNA expression of the editing enzymes ADAR1 and ADAR2
was also investigated in 46C cells. For exact values, see Table 3.
GluA2 mRNA was not expressed in undifferentiated 46C
ESCs, as has been found previously (Pachernegg et al., 2013)
(Figure 3). By contrast, 46C NEPs robustly expressed GluA2 at
the mRNA level (7.8% compared to its expression in mouse
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FIGURE 2 | Workflow of five different editing assay approaches. (A)
Restriction digest with BbvI. (B) Blunt end cloning. (C) Ligation with
subsequent restriction. (D) Sticky end cloning. (E) SLIC cloning. For all
assays, total RNA was isolated from 46C cells and control tissue (mouse
whole brain P3) and used in reverse transcriptions to generate cDNA (see
Materials and Methods).
whole brain), and its expression was highly significantly upreg-
ulated (p< 0.001; Figure 3) upon neuronal differentiation from
46C NEPs into neurons. In 46C neurons, the mRNA expres-
sion of GluA2 accounted for 62.7% of its expression in mouse
whole brain. GluA2 transcripts were slightly downregulated upon
differentiation from 46C NEPs into NSCs and from 46C NSCs
into astrocytes, respectively, although these differences in GluA2
mRNA expression were not statistically significant (Figure 3).
ADAR1 was expressed in all investigated 46C-derived cell
types at the mRNA level (Figure 4). 46C ESCs and NEPs also
already robustly expressed ADAR1 transcripts (9.7% and 25.02%,
respectively, compared to expression in mouse whole brain).
When 46C NEPs were differentiated into neurons, the mRNA
expression of ADAR1 was significantly upregulated (p< 0.01;
Figure 4), where it reached approximately half the expression
level of the control tissue (55.2% compared to its expression in
mouse whole brain). By contrast, when 46C NEPs were differ-
entiated into NSCs, the expression of ADAR1 transcripts was
downregulated (p< 0.05; Figure 4) and the mRNA expression
of ADAR1 in 46C NSCs accounted for only 3.4% compared
to its expression in mouse whole brain. Upon glial differentia-
tion from NSCs into astrocytes, ADAR1 mRNA expression again
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FIGURE 3 | Expression of GluA2 mRNA in 46C cells. The mRNA
expression of GluA2 was normalized to its expression in mouse whole brain P3
(211Ct ). GluA2 transcripts were not expressed in 46C ESCs, but in NEPs,
NSCs, neurons, and astrocytes. Its mRNA expression was significantly
upregulated when 46C NEPs were differentiated into early neurons. Data
represent means + SEM; statistical significances were assigned by One-Way
ANOVA followed by Tukey’s multiple comparison test; ***p<0.001; n.s.= not
significant; n.a.= not assigned (if the expression in at least one cell type was
0). n= 8-15 independent experiments.
increased significantly (p< 0.01; Figure 4) to 35.6% compared to
its expression in mouse whole brain.
Regarding ADAR2, the mRNA expression of two distinct
ADAR2 splice variants was investigated (Figure 5). In 1997,
it was shown that human ADAR2-short is twice as active as
ADAR2-long in editing the Q/R site of GluA2 (Gerber et al.,
1997). Similarly, rodent ADAR2 undergoes alternative splicing in
the same exon as human ADAR2. Thus, the expression of both
ADAR2-long and ADAR2-short in 46C cells was analyzed.
ADAR2-long was weakly expressed at the mRNA level in all
investigated 46C-derived cell types, with expression levels not
changing significantly upon differentiation from 46C ESCs into
NEPs, or from 46C NEPs into NSCs, respectively. Moreover, the
mRNA expression of ADAR2-long in 46CNEPs and neurons was
roughly at the same level (1.6% compared to mouse whole brain
for NEPs; 1.4% compared to mouse whole brain for neurons).
Likewise, ADAR2-short transcripts were also expressed in all
investigated 46C-derived cell types. Its mRNA expression did not
differ significantly between 46C ESCs and NEPs, or between 46C
NEPs and NSCs, or between 46C NEPs and neurons. However, in
contrast to ADAR2-long, the expression of ADAR2-short was sig-
nificantly upregulated (p< 0.01; Figure 5B) upon glial differenti-
ation from 46C NSCs into astrocytes (1.7% compared to mouse
whole brain for NSCs; 15.9% compared to mouse whole brain for
astrocytes).
In general, the mRNA expression of ADAR2-short was
higher than that of ADAR2-long in all 46C-derived cell types
FIGURE 4 | Expression of ADAR1 mRNA in 46C cells. The mRNA
expression of ADAR1 was normalized to its expression in mouse whole brain
P3 (211Ct ). ADAR1 was expressed at the mRNA level in all investigated
46C-derived cell types, and its mRNA expression was upregulated significantly
upon differentiation from 46C ESCs into NEPs and from 46C NEPs into
neurons. By contrast, ADAR1 transcripts were significantly downregulated
when 46C NEPs were differentiated into NSCs, and, subsequently, ADAR1
transcripts were significantly upregulated again following glial differentiation
from 46C NSCs into astrocytes. Data represent means + SEM; statistical
significances were assigned by One-Way ANOVA followed by Tukey’s multiple
comparison test; ∗p < 0.05; ∗∗p <0.01; n=4-8 independent experiments.
(Figure 4C). In particular, ADAR2-short transcripts were sig-
nificantly more strongly expressed in 46C ESCs (p< 0.001;
Figure 4C) and neurons (p< 0.01; Figure 4C) than ADAR2-long
transcripts. In 46C ESCs and in 46C neurons, ADAR2-short
mRNA expression was 13-fold and 7-fold higher, respectively,
than ADAR2-long mRNA expression.
Regarding the protein expression of GluA2 and ADAR2,
GluA2 protein was only expressed in the positive control (mem-
brane protein isolated from mouse whole brain P3) and in
neurons differentiated from 46C NEPs (Figure 6A). As already
described, neither 46C ESCs, NEPs, NSCs nor astrocytes dif-
ferentiated from NSCs expressed GluA2 at the protein level
(Pachernegg et al., 2013). By contrast, ADAR2 proteins were
expressed in every 46C-derived cell type (Figure 6B) including
undifferentiated 46C ESCs.
Thus, although GluA2 mRNA is not yet expressed in 46C
ESCs, its editing enzyme ADAR2 is expressed in undifferentiated
46C ESCs at both the mRNA and protein levels.
3.2. Establishment of an Editing Assay
To determine the Q/R editing state of GluA2 in 46C cells, five
different editing assay approaches were tested (Figure 2). Addi-
tionally, the R/G editing state of GluA2-GluA4 was investigated
in a limited number of samples. The published BbvI restriction
assay to analyze the Q/R editing state of GluA2 was proven to
be difficult, since the primers used in the semi-nested PCRs of
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FIGURE 5 | Expression of ADAR2-long and ADAR2-short mRNAs in
46C cells. The mRNA expression of ADAR2-long (A) and ADAR2-short (B)
was normalized to its expression in mouse whole brain P3 (211Ct ).
ADAR2-long mRNA was expressed in all 46C cells, albeit only weakly in 46C
ESCs and NSCs. Nevertheless, the mRNA expression did not differ
significantly between the different 46C-derived cell types. ADAR2-short
mRNA was expressed in all 46C cells as well, with mRNA expression levels
not differing significantly between different 46C-derived cell types except
following glial differentiation from NSCs into astrocytes. (C) Comparison of
the expression of ADAR2-long and ADAR2-short mRNAs in 46C cells. The
mRNA expression of ADAR2-short was higher in all 46C-derived cell types
than that of ADAR2-long. This difference in expression was highly significant
in 46C ESCs and neurons. Data represent means + SEM; statistical
significances were assigned by One-Way ANOVA followed by Tukey’s
multiple comparison test; ∗p < 0.01; ∗∗∗p < 0.001; n.s.= not significant.
n= 3-7 independent experiments.
GluA2 (Whitney et al., 2008) did not only amplify GluA2, but
also GluA3. Thus, a quantitative analysis of the Q/R editing of
GluA2 via the BbvI restriction assay was not possible.
The four other editing assays differed in their cloning efficien-
cies (Table 2). The most efficient cloning approach was sticky
end cloning, as 79% of the obtained sequences were indeed the
desired AMPAR sequences. SLIC and blunt end cloning yielded
roughly the same percentage of AMPAR sequences (46% and
43%, respectively). The least efficient cloning approach was the
ligation with subsequent restriction; only 24% of the sequences
obtained with this approach were AMPAR sequences. Conse-
quently, most of the AMPAR sequences were obtained by sticky
end cloning.
3.3. Q/R Editing State of GluA2 in 46C Cells
The Q/R editing state of GluA2 was investigated in all 46C-
derived cell types, namely ESCs, NEPs, NSCs, neurons, and
astrocytes, as well as in control tissue (mouse whole brain P3)
(Table 4). Approximately 10–15% of the sequences in a given cell
type were GluA3 sequences, since the semi-nested primers for
GluA2 also amplified GluA3. 46C ESCs did not express GluA2
at all, thus, all sequences obtained in this cell type were GluA3
sequences. In all other 46C-derived cell types and in mouse
whole brain, GluA2 mRNA was expressed and 102–113 individ-
ual GluA2 sequences were analyzed per cell type. In the control
tissue, 100% of GluA2 subunits were edited at the Q/R site. The
same holds true for 46C NEPs, neurons, and astrocytes. In 46C
NSCs, 106 out of 107 GluA2 sequences were edited at the Q/R
site, yielding 99% Q/R-edited GluA2 subunits in NSCs.
3.4. Q/R Editing State of GluA2 During
Differentiation from 46C ESCs to NEPs
Since 46C ESCs did not express GluA2 at all and in 46 NEPs,
100% of GluA2 was already edited at the Q/R site, the question
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FIGURE 6 | Protein expression of GluA2 and ADAR2 in 46C cells. (A)
GluA2. (B) ADAR2. A band at the expected molecular weight of GluA2
(100 kDa) was only visible in the positive control (protein isolated from mouse
whole brain P3) and in neurons differentiated from 46C NEPs. By contrast,
ADAR2 (expected molecular weight: 90 kDa) was expressed in all 46C-derived
cell types including undifferentiated ESCs. (C) Expression of calnexin as a
loading control (90 kDa). n= 3 independent experiments.
arose whether there are anyQ/R-unedited GluA2 subunits during
the differentiation from 46C ESCs to NEPs. The differentiation
from 46C ESCs to NEPs takes 9 days (Aubert et al., 2003; Ying
et al., 2003; Muth-Köhne et al., 2010a,b) and total RNA was iso-
lated from the differentiating 46C cells at various time points (d0,
d2, d4, d4.5, d5, d7, and d9 of differentiation).
The mRNA expression of GluA2 started after 4.5 days of dif-
ferentiation of 46C ESCs into NEPs. Prior to that time point, no
bands were visible in the agarose gel electrophoresis following the
RT and semi-nested PCR, and when the PCR reaction products
were directly cloned into the pSGEM vector, only contaminat-
ing co-amplified GluA3 sequences were obtained (Table 5). After
4.5, 5, 7, and 9 days of differentiation from 46C ESCs into NEPs,
GluA2 sequences were obtained. However, only after 4.5 days of
differentiation Q/R-unedited GluA2 subunits were identified (9
out of 102 total GluA2 sequences= 8.8% Q/R-unedited GluA2).
After 5, 7, and 9 days of differentiation, 100% of GluA2 was edited
at the Q/R site.
3.5. R/G Editing State and Expression of Flip/Flop
Splice Variants of AMPARs in 46C Cells
Although this study focused on the Q/R editing state of GluA2,
the R/G editing state of GluA2, GluA3, and GluA4 and the
expression of different AMPAR splice variants in 46C cells was
briefly investigated as well. To this end, specific primers were
used in the PCRs that amplify fragments of AMPARs that contain
both the R/G editing site and the flip/flop splicing region. Again,
total RNA isolated from all types of 46C-derived cells (ESCs,
NEPs, NSCs, neurons, and astrocytes) was used.
The total number of sequences obtained in the R/G edit-
ing assay was low. Nevertheless, the data clearly show that all
cell types expressed both R/G-edited and -unedited AMPARs
(Table 6), as well as both the flip and flop splice variant. This is
in stark contrast to Q/R editing, in which Q/R-unedited GluA2
subunits were substantially expressed only in a very brief time
window during the differentiation from 46C ESCs to NEPs.
4. Discussion
4.1. ADARs Are Expressed in 46C ESCs Prior to
the Onset of GluA2 Expression
In the present study, the mRNA expression of GluA2 and its
editing enzymes ADAR1 and ADAR2, as well as the protein
expression of ADAR2 and GluA2 were analyzed. ADAR1 protein
expression was not investigated, since its editing efficiency at the
Q/R site of GluA2 is relatively low compared to ADAR2 (Liu and
Samuel, 1999; Wong et al., 2001).
Regarding the mRNA expression of GluA2, it was not yet
expressed in 46C ESCs but its transcript expression started only
in NEPs, in which GluA2 was not expressed at the protein level
(see also Pachernegg et al., 2013). The mRNA expression of
GluA2 was then significantly upregulated upon neuronal differ-
entiation, and 46C neurons also expressed GluA2 protein.
By contrast, both ADAR1 and ADAR2 transcripts were
already expressed in 46C ESCs, and, for that matter, in all
46C-derived cell types. Surprisingly, ADAR2 protein was also
expressed in all investigated 46C-derived cell types, even in ESCs
and NEPs, although GluA2 protein was not expressed until dif-
ferentiation into neurons. Hence, ADAR2 expression precedes
the expression of GluA2 at both the mRNA and protein lev-
els (Figure 7). Furthermore, the mRNA expression of ADAR2
was roughly identical in 46C ESCs, NEPs, and neurons, and did
not change significantly upon neuronal differentiation, indicat-
ing that the relatively low expression of ADAR2 in compari-
son to ADAR1 is sufficient to ensure efficient Q/R editing. This
matches the reported widespread, yet weak, mRNA, and protein
expression of ADAR2 in mouse embryonic forebrain around E15
(Jacobs et al., 2009). Nevertheless, GluA2 is almost completely
edited at the Q/R site at this time point (Jacobs et al., 2009). Thus,
the authors speculate that ADAR2 preferentially edits the Q/R
site of GluA2, and that a low ADAR2 expression is sufficient for
Q/R editing of all GluA2 transcripts present (Jacobs et al., 2009).
Additionally, the overall transcript expression of ADAR2-
short was higher than the transcript expression of ADAR2-long
in all 46C cell types. Human ADAR2-short is twice as active as
ADAR2-long in editing the Q/R site of GluA2 (Gerber et al.,
1997). The predominant expression of ADAR2-short compared
to ADAR2-long also hints at the establishment of a pool of
ADAR2 in 46C ESCs and NEPs to rapidly edit GluA2 at the
Q/R site.
By contrast, the mRNA expression of ADAR1, which is
mainly involved in the developmentally gradually increasing
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TABLE 2 | Efficiency of four different editing assays.
Cloning approach Number of sequences
AMPAR Different gene Empty plasmid Total 95% CI (AMPAR sequence)
Sticky end 813 (79%) 185 (18%) 30 (3%) 1029 786 (76%)—837 (81%)
SLIC 63 (46%) 25 (18%) 48 (35%) 136 52 (38%)—74 (54%)
Blunt end 357 (43%) 155 (18%) 330 (39%) 842 329 (39%)—385 (46%)
Restriction after ligation 52 (24%) 48 (23%) 114 (53%) 214 41 (19%)—65 (30%)
Following different subcloning methods, the inserts of the plasmid DNAs of individual colonies were sequenced. Below, the results of four different approaches are listed, sorted by
the percentage of AMPAR sequences obtained. Ninety five percent confidence intervals were calculated using the modified Wald method. AMPAR=AMPAR sequence successfully
subcloned into pSGEM; Different gene=different gene sequence subcloned into pSGEM; Empty plasmid= re-ligated pSGEM; Total= total number of sequences obtained by each
cloning approach; CI= confidence intervals.
TABLE 3 | Expression of GluA2, ADAR1, and ADAR2 mRNAs in 46C cells.
Cell type GluA2 ADAR1 ADAR2-long ADAR2-short
mRNA expression levels (%) normalized to housekeeping genes
46C ESCs 0 1.387±0.216 0.039±0.008 0.252±0.042
46C NEPs 0.451±0.176 3.565±0.591 0.373±0.264 0.897±0.291
46C NSCs 0.1875± 0.086 0.489±0.118 0.028±0.006 0.191±0.109
46C neurons 3.599± 0.725 7.864±1.604 0.326±0.097 1.031±0.219
46C astrocytes 0.102± 0.022 5.074±0.983 0.673±0.505 1.791±0.629
mRNA expression levels (%) normalized to mouse whole brain
46C ESCs 0 9.7±1.52 0.16±0.04 2.2±0.37
46C NEPs 7.8±3.07 25.02± 4.17 1.6±1.1 7.4±2.6
46C NSCs 3.3±1.54 3.4±0.82 0.1±0.02 1.7± 0.97
46C neurons 62.7±12.64 55.2±11.26 1.4±0.4 9.1±1.9
46C astrocytes 1.7±0.39 35.6± 6.89 2.8±2.1 15.9±5.59
The mRNA expression of GluA2, ADAR1, ADAR2-long, and ADAR2-short was normalized to the expression of the housekeeping genes β-actin, GAPDH, and ubiquitin (21Ct ) and to
their expression in mouse whole brain (211Ct ). Data represent means ± SEM; n=3-15 independent experiments.
TABLE 4 | Q/R editing state of GluA2 in 46C cells.
Cell/tissue type Number of sequences
Edited GluA2/Total GluA2 GluA3 Total 95% Confidence intervals (edited GluA2)
46C ESCs n.a. 26 26 n.a.
46C NEPs 113/113 (100%) 11 124 108 (95.6%)—113 (100%)
46C NSCs 106/107 (99.1%) 10 117 101 (94.4%)—107 (100%)
46C neurons 105/105 (100%) 12 117 100 (95.2%)—105 (100%)
46C astrocytes 105/105 (100%) 10 115 100 (95.2%)—105 (100%)
mouse whole brain P3 102/102 (100%) 11 113 97 (95.1%)—102 (100%)
The results obtained by sequencing GluA2 from individual bacterial colonies are given below. Additionally, the numbers of GluA3 sequences unintentionally co-amplified in the RT-PCR
are listed. Ninety five percent confidence intervals were calculated using the modified Wald method. n.a.= no sequences obtained due to lack of expression; Total= total number of
sequences obtained for each cell/tissue type.
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TABLE 5 | Q/R editing state of GluA2 during the differentiation from 46C ESCs into NEPs.
Time point of differentiation Number of sequences
Edited GluA2/Total GluA2 GluA3 Total 95% Confidence intervals (edited GluA2)
d0 (46C ESCs) n.a. 9 9 n.a.
d2 n.a. 11 11 n.a.
d4 n.a. 15 15 n.a.
d4.5 93/102 (91.1%) 11 113 85 (83.3%)—97 (95.1%)
d5 108/108 (100%) 12 120 103 (95.4%)—108 (100%)
d7 112/112 (100%) 10 122 107 (95.5%)—112 (100%)
d9 (46C NEPs) 107/107 (100%) 11 118 102 (95.3%)—107 (100%)
The results obtained by sequencing GluA2 are given below. Additionally, the numbers of GluA3 sequences unintentionally co-amplified in the RT-PCR are listed. Ninety five percent con-
fidence intervals were calculated using the modified Wald method. d=day of differentiation; n.a.= no sequences obtained due to lack of expression; Total= total number of sequences
obtained for each time point.
TABLE 6 | Flip/flop splice variant and R/G editing state of AMPARs in 46C cells.
AMPAR Splice variant R/G editing site Total 95% CI (Flip) 95% CI (R/G-unedited)
Flip Flop Unedited Edited
46C ESCs
GluA1 6 (60%) 4 (40%) – – 10 3 (30%)—8 (80%) –
GluA2 n.a. n.a. n.a. n.a. n.a. n.a. n.a.
GluA3 12 (92%) 1 (8%) 9 (69%) 4 (31%) 13 8 (61%)—13 (100%) 5 (38%)—11 (85%)
GluA4 8 (100%) 0 (0%) 7 (88%) 1 (12%) 8 5 (62%)—8 (100%) 4 (50%)—8 (100%)
46C NEPs
GluA1 5 (83%) 1 (17%) – – 6 2 (33%)—6 (100%) –
GluA2 7 (78%) 2 (22%) 9 (100%) 0 (0%) 9 4 (44%)—8 (89%) 6 (67%)—9 (100%)
GluA3 4 (80%) 1 (20%) 3 (60%) 2 (40%) 5 2 (40%)—5 (100%) 1 (20%)—4 (80%)
GluA4 6 (100%) 0 (0%) 6 (100%) 0 (0%) 6 3 (50%)—6 (100%) 3 (50%)—6 (100%)
46C NSCs
GluA1 0 (0%) 7 (100%) – – 7 0 (0%)—3 (43%) –
GluA2 6 (100%) 0 (0%) 1 (17%) 5 (83%) 6 3 (50%)—6 (100%) 0.06 (1%)—3 (50%)
GluA3 12 (100%) 0 (0%) 0 (0%) 12 (100%) 12 8 (67%)—12 (100%) 0 (0%)—3 (25%)
GluA4 1 (100%) 0 (0%) 0 (0%) 1 (100%) 1 0.16 (16%)—1 (100%) 0 (0%)—0.83 (83%)
46C neurons
GluA1 7 (100%) 0 (0%) – – 7 4 (57%)—7 (100%) –
GluA2 9 (100%) 0 (0%) 7 (78%) 2 (22%) 9 6 (67%)—9 (100%) 4 (44%)—8 (89%)
GluA3 4 (100%) 0 (0%) 2 (50%) 2 (50%) 4 2 (50%)—4 (100%) 0.6 (15%)—3 (75%)
GluA4 8 (89%) 1 (11%) 8 (89%) 1 (11%) 9 8 (89%)—9 (100%) 8 (89%)—9 (100%)
46C astrocytes
GluA1 6 (86%) 1 (14%) – – 7 3 (43%)—7 (100%) –
GluA2 8 (89%) 1 (11%) 0 (0%) 9 (100%) 9 5 (55%)—9 (100%) 0 (0%)—3 (33%)
GluA3 6 (100%) 0 (0%) 2 (33%) 4 (67%) 6 3 (50%)—6 (100%) 0.5 (8%)—4 (67%)
GluA4 11 (100%) 0 (0%) 0 (0%) 11 (100%) 11 8 (73%)—11 (100%) 0 (0%)—3 (27%)
The results obtained by sequencing PCR-amplified and subcloned AMPAR fragments are given below. Ninety five percent confidence intervals were calculated using the modified Wald
method. n.a.= no sequences obtained due to lack of AMPAR expression;−= lack of R/G editing in GluA1; Total= total number of sequences obtained for each subunit; CI= confidence
intervals.
R/G editing, significantly increases during differentiation of 46C-
derived cells. Furthermore, ADAR1mRNAs aremore abundantly
expressed than ADAR2 transcripts. In general, ADAR1 seems to
have a higher impact on the development of the haematopoi-
etic system than on neural development: ADAR1 knockout (KO)
mice die early during embryonic development due to failures
in the haematopoietic system (Wong and Lazinski, 2002), but
they do not show abnormalities related to brain development.
Furthermore, ADAR1 was shown to be essential for the sur-
vival of haematopoietic progenitor cells (XuFeng et al., 2009).
It might be that 46C-derived cells express ADAR1 targets apart
from AMPARs and that editing of these targets might be crucial
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FIGURE 7 | Comparison of ADAR, GluA2 mRNA and protein expression
time lines during neural differentiation of 46C ESCs. The expression of
ADAR2-short (blue line) precedes the expression of GluA2 (red line) at both the
mRNA and protein levels. ADAR2-short mRNA expression was roughly the
same in 46C ESCs, NEPs, and neurons, whereas the transcript expression of
both ADAR1 and GluA2 increased significantly upon neuronal differentiation.
Moreover, the mRNA expression of ADAR1 (green line) was also significantly
higher in 46C NEPs than in ESCs. The upregulation of ADAR1 may be related
to the gradual increase of R/G editing during neural development. Furthermore,
ADAR2-short was already expressed at the protein level in undifferentiated
46C ESCs and NEPs, whereas GluA2 proteins were only detectable after
neuronal differentiation. Note that the mRNA expression of ADAR2-long was
not depicted here for simplification. Data represent means ± SEM; statistical
significances were assigned by One-Way ANOVA followed by Tukey’s multiple
comparison test; ∗p < 0.05; ∗∗p < 0.01; n=3-15 independent experiments.
for the survival of ESCs. However, the target gene(s) of ADAR1
which cause the lethal phenotype of ADAR1 KO mice remain
unknown thus far (Riedmann et al., 2008).
4.2. Establishment of an Editing Assay
To analyze the Q/R editing state of GluA2 in 46C cells, five dif-
ferent editing assays were tested: BbvI restriction digest and four
sequencing-based assays relying on blunt end cloning, ligation
with subsequent restriction, sticky end cloning, or SLIC cloning.
The BbvI restriction digest assay (Whitney et al., 2008) is
based on the fact that the 271 bp long GluA2 fragment ampli-
fied by semi-nested PCRs contains two restriction sites for BbvI
when the Q/R site is unedited and only one BbvI site when
it is edited. Thus, Q/R-unedited and -edited GluA2 subunits
yield different restriction digest patterns upon restriction with
BbvI. However, approximately 10–15% of the DNA fragments
represented contaminating GluA3 rather than GluA2 sequences,
as revealed by DNA sequencing performed during the other edit-
ing assays. Given the high sequence identity of AMPARs and only
minor differences in the published primer binding sites between
GluA2 and GluA3 (1 and 2 bases for the sense and antisense
primers, respectively) it is comprehensible that GluA3 was eas-
ily co-amplified in the semi-nested PCRs. This is of particular
importance for 46C ESCs (and other cells), in which GluA3 but
not yet GluA2 is expressed at the mRNA level. The unintended
co-amplification of GluA3 will distort the results in the BbvI
restriction assay, since GluA3 contains two restriction sites for
BbvI as well. GluA3 is never edited at the Q/R site, and a restric-
tion digest of the amplified GluA3 fragment with BbvI will always
yield three DNA fragments (151 bp, 81 bp, and 45 bp) that in
practice are indistinguishable from DNA fragments obtained by
the restriction of Q/R-unedited GluA2 (145 bp, 80 bp, and 46 bp).
Thus, the BbvI restriction assay is not suitable for investigating
the Q/R editing state of GluA2, because the unavoidable con-
tamination by GluA3 inevitably leads to overestimation of the
fraction of Q/R-unedited GluA2. Rather, an approach including
the sequencing of DNA fragments should be chosen that allows
to sort out the contaminating GluA3 sequences.
The other four editing assays were all based on the subcloning
of PCR fragments into the pSGEM vector, its transformation into
bacteria, and the subsequent preparation and sequencing of plas-
mid DNA. By doing so, not only the co-amplification of GluA3
could be monitored, but by subcloning the PCR fragments into
bacteria a high number of sequences for a reliable statistical eval-
uation could be obtained as well, since this method allows to
sequence the plasmid DNA of many individual bacterial colonies.
Ultimately, the four sequencing-based editing assays differed
only in the way the PCR fragments were subcloned into the
pSGEM vector. In this regard, the best approach turned out to be
sticky end cloning, which yielded the highest percentage (approx-
imately 80%) of AMPAR-specific sequences. For the editing assay,
as many informative plasmid/insert constructs as possible should
be obtained to increase the number of total sequences and thus
improve the statistics. In order to do so, most GluA2 sequences
were thus obtained by sticky end cloning in this study.
4.3. GluA2 is Rapidly Edited at the Q/R Site
During Differentiation from 46C ESCs to NEPs
After establishing a reliable editing assay, the Q/R editing state
of GluA2 in 46C-derived cells was determined. As mentioned
above, GluA2 mRNA was not yet expressed in undifferentiated
46C ESCs, but in NEPs. In 46CNEPs, 100% of GluA2 was already
edited at the Q/R site, and, likewise, GluA2 was completely Q/R-
edited in neurons and astrocytes. Only in 46C NSCs, a single
Q/R-unedited GluA2 sequence (out of 107 sequences in total) was
identified.
Furthermore, the Q/R editing state of GluA2 was analyzed in
more detail at various time points during the differentiation of
46C ESCs into NEPs, which takes 9 days to complete (Aubert
et al., 2003; Ying et al., 2003; Muth-Köhne et al., 2010a,b). GluA2
transcript expression set in after 4.5 days of differentiation of
46C ESCs into NEPs, and at this time point, less than 10% of
GluA2 subunits were unedited at the Q/R site. Only 0.5 days
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later, at day 5 of differentiation, GluA2 was already completely
Q/R-edited.
Although the exact onset of Q/R editing during neural devel-
opment in vivo is still a matter of debate, Q/R editing undoubt-
edly is more rapid and thorough than R/G editing, which
increases only gradually and never reaches 100%, not even in
adults (Lomeli et al., 1994; Geiger et al., 1995; Lai et al., 1997;
Orlandi et al., 2011). It is possible that a pool of ADAR2 is estab-
lished in ESCs and NEPs to ensure the rapid Q/R editing of
GluA2 as soon as the mRNA expression of GluA2 sets in in NEPs.
Moreover, when GluA2 is finally expressed at the protein level
in neurons, the vast majority, if not all, GluA2 subunits will be
edited at the Q/R site. Our data is in line with previous stud-
ies, which showed that GluA2 is already almost completely Q/R-
edited in the embryonic and postnatal brain (Longone et al., 1998;
Kawahara et al., 2004; Jacobs et al., 2009; Wahlstedt et al., 2009;
Shtrichman et al., 2012).
It is important to note that ADAR2 expression and GluA2
Q/R editing are not linearly related. The editing assay in this
study does not detect Q/R-unedited GluA2 pre-mRNA, since the
primers used in this assay span at least one exon-exon junc-
tion. Thus, putative Q/R-unedited GluA2 pre-mRNA was not
detected in this study and could be present both in ESCs and
NEPs. However, the basal expression of ADAR2 in ESCs and
its increase of expression after differentiation into NEPs argue
against a substantial amount of Q/R-unedited GluA2 pre-mRNA
in these cells.
The importance of ADAR2 and Q/R editing was proven by
the generation of KO animals. Homozygous ADAR2−/− mice
die between P0 and P21 and are subject to seizures, presumably
caused by the 30-fold higher Ca2+ permeability and higher sin-
gle channel conductance of AMPARs with Q/R-unedited GluA2
subunits in CA1 pyramidal neurons (Higuchi et al., 2000). Inter-
estingly, the severe effect of ADAR2 KO can be rescued by
introducing a “pre-edited” GluA2 gene. Moreover, heterozygous
ADAR2−/−/GluA2+/R mice, in which only one allele of GluA2
expresses GluA2(R), are also partially rescued: Their phenotype is
less impaired than that of ADAR2−/−mice and they survive until
P35 (Higuchi et al., 2000). Homozygous ADAR2−/−/GluA2R/R
mice, in which both alleles of GluA2 express GluA2(R), are fully
rescued and show no abnormality in postnatal development or
general behavior (Higuchi et al., 2000). Thus, it appears that
GluA2 is the most important substrate for ADAR2 in terms of
viability. In addition, heterozygous GluA21ECS mice, in which
the Q/R editing of GluA2 is abolished due to a mutation in the
editing-determining exon complementary sequence (ECS), die at
P20 and show an early onset of epilepsy like ADAR2−/− mice
(Brusa et al., 1995; Feldmeyer et al., 1999). Altogether, these find-
ings point to a crucial role of Q/R editing of GluA2 during embry-
onic and neonatal development. Thus, it is unlikely that the early
onset of ADAR2 expression in 46C cells is (substantially) linked
to the editing of a target mRNA other than GluA2.
In contrast to our data, Whitney et al. (2008) found approx-
imately 60% of Q/R-unedited GluA2 subunits in human neural
progenitor cells. The diverging results might be caused by the
differences between human and murine cells. However, Whit-
ney et al. (2008) had used the BbvI restriction assay, which is
not well-suited to detect Q/R-unedited GluA2 subunits, since it
also cross-detects GluA3 subunits that are never edited at the
Q/R site. In the present study, in every investigated cell type (and
in the control tissue mouse whole brain) approximately 10–15%
of obtained sequences were GluA3 sequences, which would have
been regarded as “Q/R-unedited GluA2” subunits with the BbvI
restriction assay. Thus, the extent of Q/R-unedited GluA2 sub-
units in human neural progenitor cells is probably substantially
lower than reported, if there are any at all. Furthermore, there
is increasing evidence that Ca2+-permeable AMPARs lacking
GluA2 subunits play an important role in NMDAR-independent
LTP triggering (Jia et al., 1996; Harvey et al., 2001; Meng et al.,
2003; Wiltgen et al., 2010). However, Ca2+-permeable AMPARs
that contain Q/R-unedited GluA2 subunits have not been iden-
tified in the healthy brain thus far, but only following ischemia
(Peng et al., 2006) or in motor neurons of ALS patients (Kwak
and Kawahara, 2005). Thus, while Whitney et al. (2008) found
Ca2+-permeable AMPARs in human neural progenitor cells, it is
likely that a majority of these receptors were composed of GluA1,
GluA3, or GluA4 subunits, but did not contain Q/R-unedited
GluA2 subunits. Furthermore, GluA2R/R mice, which are genet-
ically edited at the Q/R site, are viable and show no differences
in brain architecture (Kask et al., 1998). Our findings support the
hypothesis that Q/R-unedited GluA2 does not play a role dur-
ing neural development (Kask et al., 1998), but is rather rapidly
edited at the Q/R site as soon as GluA2 mRNA expression sets
in. Moreover, the severe effects of ADAR2 KO, which can be
rescued by “pre-edited” GluA2, argue against a significant expres-
sion of Q/R-unedited GluA2 subunits during neural development
(Higuchi et al., 2000).
4.4. AMPARs Are Not Fully Edited at the R/G Site
in 46C Cells
Although this study focused on the Q/R editing state of GluA2,
for which the bulk of the data has been collected, it is obvious
from the data obtained for the R/G editing site that AMPARs
are not as rapidly and efficiently edited at the R/G site during
neural development as GluA2 is at the Q/R site. In all investi-
gated 46C cell types, R/G-unedited subunits are expressed at the
mRNA level. Moreover, AMPARs are not expressed at the pro-
tein level in 46C ESCs or NEPs (Pachernegg et al., 2013), and
once AMPAR protein expression sets in after differentiation into
neurons, both R/G-edited and -unedited AMPARs can be found
expressed. This is consistent with previous studies that reported
a gradual increase of R/G editing during neural development
(Lomeli et al., 1994; Geiger et al., 1995; Lai et al., 1997; Orlandi
et al., 2011). Hence, the 46C cell system is well-suited to inves-
tigate the editing state of AMPARs during neural development
since it faithfully mimics the conditions in vivo.
4.5. Conclusions
This study analyzed for the first time the precise onset of GluA2
mRNA expression during differentiation of ESCs into NEPs, and,
additionally, the exact onset of Q/R editing during this time
course. GluA2 subunits are rapidly edited during neural differ-
entiation, and Q/R-unedited GluA2 subunits are only present
within a very brief time window. The preceding expression of
ADAR2 both at the mRNA and protein levels argues for the pres-
ence of a pool of ADAR2 in undifferentiated ESCs to ensure
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the rapid Q/R editing of GluA2. These results partly contradict
literature data. However, in the present study, the Q/R edit-
ing state of GluA2 was determined with a more reliable editing
assay than in previous studies. In future studies, the physiolog-
ical consequences of the rapid onset of Q/R editing should be
investigated.
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